Metformin promotes susceptibility to experimental Leishmania braziliensis infection

BACKGROUND: Metformin (MET) is a hypoglycemic drug used for the treatment of diabetes, despite interference in host immunity against microorganisms. Cutaneous infection caused by pathogens such as Leishmania braziliensis (Lb), the agent responsible for cutaneous leishmaniasis (CL) in Brazil, represe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mem Inst Oswaldo Cruz
Huvudupphovsmän: Lima, Filipe Rocha, Ferreira, Lais de Melo, Malta, Tainá Alves, Bonyek-Silva, Icaro, Santos, Reinan Lima, Tavares, Natália Machado, de Carvalho Filho, Edgar Marcelino, Arruda, Sérgio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7668079/
https://ncbi.nlm.nih.gov/pubmed/33206822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760200272
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk